Altana Licenses Spotfire DecisionSite Software

Nov 01, 2004

NEW YORK, Nov. 1 (GenomeWeb News) - Spotfire today said that Altana Pharma has licensed its Spotfire DecisionSite software worldwide for research, lead discovery, and clinical safety in four separate labs.

The drug maker currently uses the software in functional genomics and lead discovery research, Spotfire said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Last of the Northern White Rhinoceroses, Sequenced

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

DNA Phenotyping Allowed in Bavaria

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Thanks for the Stress, Dad

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

This Week in Science

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Main menu